The U.S. FDA Bioresearch Monitoring Program was introduced
In 1977, the U.S. Food and Drug Administration (FDA) established the Bioresearch Monitoring Program (BiMo) to develop cross-center…
In 1977, the U.S. Food and Drug Administration (FDA) established the Bioresearch Monitoring Program (BiMo) to develop cross-center…
On Apr. 22, 1976, the U.S. Congress passed the Vitamin-Mineral Amendment to the Federal Food, Drug, and Cosmetic…
In 1976, Influenza A/Victoria-like strains had been identified in New Jersey as early as January 21. The novel…
In 1976, the U.S. Congress passed the Medical Device Amendments to ensure safety and effectiveness of medical devices,…
In 1975, rapamycin, a macrolide produced by the bacterium Streptomyces hygroscopicus was first discovered and isolated from soil…
In Jul. 1974, In the Division of Pharmaceutical Service at the University of Iowa began producing cGMP compliant…
In 1974, the U.S. Food and Drug Administration (FDA) approved doxorubicin (Adriamycin), an antitumor anthracycline antibiotic from Streptomyces…
On Jun. 18, 1973, the U.S. Supreme Court upheld the 1962 drug effectiveness law and endorsed FDA action…
On Oct. 27, 1972, the Consumer Product Safety Commission (CPSA) was enacted by Congress. The CPSA assumed programs…
On Jul. 1, 1972, the Regulation of Biologics–including serums, vaccines, and blood products–was transferred from the NIH to…
In 1972, the Division of Biologics Standards was transferred from NIH to FDA and renamed the Bureau of…
In 1972, the FDA’s new Bureau of Biologics began to regulate all 7000 U.S. blood and plasma centers….
On Sept. 29, 1971, the artificial sweetener saccharin, included in FDA’s original GRAS list, was removed from the…
On May 17, 1971, The Public Health Service’s Bureau of Radiological Health was transferred to the FDA.
In 1971, The PHS Bureau of Radiological Health transferred to FDA. Its mission: protection against unnecessary human exposure…
On Feb. 27, 1970, in Upjohn v. Finch the Court of Appeals upheld enforcement of the 1962 drug…
In 1970, the FDA required the first patient package insert: oral contraceptives must contain information for the patient…
On Dec. 13, 1969, Charles Edwards, M.D., becomes FDA commissioner.
On Dec. 2, 1969, the White House Conference on Food, Nutrition, and Health recommended systematic review of GRAS…
On Sept. 4, 1969, the FDA issued a report that called birth control pills safe, despite a slight…
In 1969, the FDA began administering Sanitation Programs for milk, shellfish, food service, and interstate travel facilities, and…
On Nov. 26, 1968, the U.S. Food and Drug Administration (FDA) licensed a second live, further attenuated measles…
On Apr. 7, 1968, the FDA Bureau of Drug Abuse Control and Treasury Department Bureau of Narcotics were…
In March 1968, a reorganization of federal health programs placed the U.S. Food and Drug Administration (FDA) in…
In 1968, The FDA formed the Drug Efficacy Study Implementation (DESI) to implement recommendations of the National Academy…
In 1968, Medtronic annual sales skyrocketed to more than $12 million, with the company reporting net income in…
In 1967, Medtronic introduced two “on-demand” pacemakers, designed to avoid competition between paced beats and the patient’s own…
On Nov. 3, 1966, the Child Protection Act was passed by the U.S. Congress. The bill enlarged the…
On Jun. 8, 1965, FDA appointed science advisors to stimulate career development.
In 1966, the Fair Packaging and Labeling Act required all consumer products in interstate commerce to be honestly…